Karyopharm Therapeutics Inc Cash Flow Quality Index
Karyopharm Therapeutics Inc cash flow quality index. Karyopharm Therapeutics Inc (KPTI) has a Cash Flow Quality Index of -1.62x as of June 2024. Operating cash flow of $-38.50 Million is below net income of $23.79 Million, suggesting accrual-heavy earnings not yet converted to cash. See Karyopharm Therapeutics Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Karyopharm Therapeutics Inc Cash Flow Quality Index by Year (None–None)
Karyopharm Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Karyopharm Therapeutics Inc. For the full cash flow conversion analysis, see KPTI cash generation efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|